Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High rifampicin-resistant TB cure rates and prevention of severe ototoxicity after replacing the injectable by linezolid in early stage of hearing loss.
Souleymane MB, Piubello A, Lawan IM, Hassane-Harouna S, Assao-Neino MM, Soumana A, Hamidou-Harouna Z, Gagara-Issoufou A, Ortuño-Gutiérrez N, Roggi A, Schwoebel V, Mamadou S, Lynen L, De Jong B, Van Deun A, Decroo T. Souleymane MB, et al. Among authors: mamadou s. Eur Respir J. 2021 Jan 21;57(1):2002250. doi: 10.1183/13993003.02250-2020. Print 2021 Jan. Eur Respir J. 2021. PMID: 32703777 Free article.
Management of multidrug-resistant tuberculosis with shorter treatment regimen in Niger: Nationwide programmatic achievements.
Piubello A, Souleymane MB, Hassane-Harouna S, Yacouba A, Lempens P, Assao-Neino MM, Maman-Lawan I, Attaher S, Moustapha B, Soumana A, Gagara-Issoufou A, Ortuño-Gutiérrez N, Roggi A, Gumusboga M, Hamidou-Harouna Z, Dockx J, Mamadou S, de Jong BC, Decroo T, Van Deun A. Piubello A, et al. Among authors: mamadou s. Respir Med. 2020 Jan;161:105844. doi: 10.1016/j.rmed.2019.105844. Epub 2019 Nov 23. Respir Med. 2020. PMID: 32056722 Free article.
Definitive outcomes in patients with rifampicin-resistant tuberculosis treated in Niger from 2012 to 2019: A retrospective cohort study.
Souleymane MB, Decroo T, Mamadou S, Soumana A, Lawan IM, Gagara-Issoufou A, Adehossi E, Ortuño-Gutiérrez N, Lynen L, Rigouts L, de Jong BC, Van Deun A, Piubello A. Souleymane MB, et al. Among authors: mamadou s. Int Health. 2023 May 2;15(3):258-264. doi: 10.1093/inthealth/ihac016. Int Health. 2023. PMID: 35420123 Free PMC article.
Safety, effectiveness, and adherence of a short and all-oral treatment regimen for the treatment of rifampicin-resistant tuberculosis in Niger: a study protocol of a pragmatic randomised clinical trial with stratified block randomisation.
Souleymane MB, Decroo T, Soumana A, Maman Lawan I, Gagara-Issoufou A, Halidou-Moussa S, Ortuño-Gutiérrez N, Adehossi E, Mamadou S, Van Deun A, Piubello A. Souleymane MB, et al. Among authors: mamadou s. Trials. 2022 Dec 13;23(1):1011. doi: 10.1186/s13063-022-06912-7. Trials. 2022. PMID: 36514153 Free PMC article.
Laboratory organisation and management of SARS-CoV-2 infection in Niger, West Africa.
Yacouba A, Lagaré A, Maiga DA, Sambo HM, Ousmane S, Harouna ZH, Marou B, Sanoussi MK, Aoula B, Amadou A, Boureima H, Amatagas S, Ousmane A, Adehossi E, Mamadou S. Yacouba A, et al. Among authors: mamadou s. Afr J Lab Med. 2020 Dec 21;9(1):1308. doi: 10.4102/ajlm.v9i1.1308. eCollection 2020. Afr J Lab Med. 2020. PMID: 33392057 Free PMC article.
29 results